NO20054148L - Nytt medikament - Google Patents

Nytt medikament

Info

Publication number
NO20054148L
NO20054148L NO20054148A NO20054148A NO20054148L NO 20054148 L NO20054148 L NO 20054148L NO 20054148 A NO20054148 A NO 20054148A NO 20054148 A NO20054148 A NO 20054148A NO 20054148 L NO20054148 L NO 20054148L
Authority
NO
Norway
Prior art keywords
new drug
zero
8alkenyl
8alkyl
thiazolyl
Prior art date
Application number
NO20054148A
Other languages
English (en)
Norwegian (no)
Inventor
Jessica Mann
Original Assignee
Speedel Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Pharma Ag filed Critical Speedel Pharma Ag
Publication of NO20054148L publication Critical patent/NO20054148L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20054148A 2003-03-06 2005-09-06 Nytt medikament NO20054148L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03100549A EP1454625A1 (en) 2003-03-06 2003-03-06 Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies
PCT/EP2004/050242 WO2004078104A2 (en) 2003-03-06 2004-03-03 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy

Publications (1)

Publication Number Publication Date
NO20054148L true NO20054148L (no) 2005-09-06

Family

ID=32799012

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054148A NO20054148L (no) 2003-03-06 2005-09-06 Nytt medikament

Country Status (26)

Country Link
US (2) US20060094731A1 (pt)
EP (2) EP1454625A1 (pt)
JP (1) JP4737686B2 (pt)
KR (1) KR101099189B1 (pt)
CN (1) CN100453081C (pt)
AT (1) ATE395063T1 (pt)
AU (2) AU2004216858B2 (pt)
BR (1) BRPI0408082A (pt)
CA (1) CA2517930C (pt)
CY (1) CY1108241T1 (pt)
DE (1) DE602004013734D1 (pt)
DK (1) DK1601361T3 (pt)
EC (1) ECSP056060A (pt)
ES (1) ES2305737T3 (pt)
HR (1) HRP20050860A2 (pt)
IL (1) IL170626A (pt)
MX (1) MXPA05009478A (pt)
NO (1) NO20054148L (pt)
NZ (1) NZ542155A (pt)
PL (1) PL1601361T3 (pt)
PT (1) PT1601361E (pt)
RS (1) RS20050683A (pt)
SI (1) SI1601361T1 (pt)
UA (1) UA82087C2 (pt)
WO (1) WO2004078104A2 (pt)
ZA (1) ZA200507122B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1595880A1 (en) * 2004-05-13 2005-11-16 Speedel Pharma AG Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists
EP1924325A2 (en) * 2005-09-12 2008-05-28 Speedel Pharma AG Pyridylsulfonamidyl-pyrimidines for the prevention of blood vessel graft failure
CA2802414C (en) 2010-06-17 2018-01-09 Nitto Denko Corporation Agent for treating renal fibrosis
CN109260164A (zh) * 2018-10-07 2019-01-25 威海贯标信息科技有限公司 一种阿伏生坦片剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76542A (en) * 1994-03-17 1997-09-29 Ciba Geigy Ag Use of valsartan for the preparation of pharmaceutical composition serving for the treatment of diabetic nephropathy
CA2162630C (en) * 1994-11-25 2007-05-01 Volker Breu Sulfonamides
DE69626986T2 (de) * 1995-08-02 2004-02-05 Smithkline Beecham Corp. Endothelinrezeptorantagonist
US6417360B1 (en) * 1999-03-03 2002-07-09 Hoffmann-La Roche Inc. Heterocyclic sulfonamides
AU2001263850A1 (en) * 2000-04-20 2001-11-07 Actelion Pharmaceuticals Ltd Pyrimidine-sulfonamides having endothelin-antagonist activity

Also Published As

Publication number Publication date
NZ542155A (en) 2008-09-26
EP1454625A1 (en) 2004-09-08
UA82087C2 (uk) 2008-03-11
ATE395063T1 (de) 2008-05-15
RS20050683A (sr) 2007-11-15
CA2517930A1 (en) 2004-09-16
DE602004013734D1 (de) 2008-06-26
JP4737686B2 (ja) 2011-08-03
JP2006519817A (ja) 2006-08-31
ES2305737T3 (es) 2008-11-01
ZA200507122B (en) 2006-05-31
KR101099189B1 (ko) 2011-12-27
WO2004078104A3 (en) 2004-10-28
US20090005404A1 (en) 2009-01-01
CN100453081C (zh) 2009-01-21
CN1756552A (zh) 2006-04-05
EP1601361B1 (en) 2008-05-14
DK1601361T3 (da) 2008-08-25
KR20050106083A (ko) 2005-11-08
BRPI0408082A (pt) 2006-02-14
IL170626A (en) 2010-05-31
PT1601361E (pt) 2008-07-29
AU2004216858B2 (en) 2009-07-16
EP1601361A2 (en) 2005-12-07
PL1601361T3 (pl) 2008-10-31
AU2009225323A1 (en) 2009-11-05
US20060094731A1 (en) 2006-05-04
SI1601361T1 (sl) 2008-10-31
CY1108241T1 (el) 2013-09-04
CA2517930C (en) 2011-04-26
HRP20050860A2 (en) 2005-10-31
AU2004216858A1 (en) 2004-09-16
MXPA05009478A (es) 2005-10-18
ECSP056060A (es) 2006-01-27
HK1083761A1 (en) 2006-07-14
AU2009225323B2 (en) 2011-11-24
WO2004078104A2 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
ATE453393T1 (de) Verwendung von pyridylamiden als angiogenesehemmer
DK2114933T3 (da) Piperidin-GPCR-agonister
ATE478044T1 (de) Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c
NO20052796L (no) Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese
DK1613304T3 (da) DPP-IV-inhibitorer
DK1855677T3 (da) 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
AR045959A1 (es) Derivados de pirazolo- e imidazo-pirimidina
NO20082118L (no) Heterocykliske CETP-inhibitorer
CY1113171T1 (el) Αντιφλεγμονωδεις παραγοντες
BR0307894A (pt) Heterocìclos tricìclicos fundidos úteis para o tratamento de distúrbios hiperproliferativos
NO20070974L (no) Substituerte N-acyl-2-aminotiazoler
CY1108241T1 (el) Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας
GB0412314D0 (en) Compounds
SE0200198D0 (sv) New use
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
TW200728291A (en) Amide derivatives
EA200800151A1 (ru) Производные хинолина в качестве антибактериальных агентов
ATE338046T1 (de) 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza- cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität
DK1924255T3 (da) Anvendelse af N-(dibenz(B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamin (OMIGAPIL) til profylakse og/eller behandling af muskeldystrofi
AR052553A1 (es) Derivados de benzoil -tetrahidropiridina
DK1409490T3 (da) 2-(Aminomethyl)tetrahydro-9-oxa-1,3-diazacyclopenta[a]-naphthalenylderivater med antipsykotisk virkning
TH82384A (th) อนุพันธ์แอริล 1,4-ไพราซินที่ถูกแทนที่
TH76971A (th) อนุพันธ์ไตรไซคลิกที่ถูกหลอม
TH80960A (th) ซัลฟานิลแทนที่ฟีนิลเมทธาโนนซ์
ATE527267T1 (de) 1-ä2',3'-didesoxy-3'-c(hydroxymethyl)-b-d-eryth o-pentofuranosylü cytosinderivate als hiv- inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application